These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36093764)

  • 1. Morphea disease activity during pregnancy: A case series.
    Walker AM; Bermas BL; Jacobe HT
    J Dermatol; 2022 Dec; 49(12):1278-1283. PubMed ID: 36093764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of the Performance of Current Morphea Subtype Classifications.
    Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
    JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Disease Activity and Damage Over Time in Patients With Morphea.
    O'Brien JC; Nymeyer H; Green A; Jacobe HT
    JAMA Dermatol; 2020 May; 156(5):513-520. PubMed ID: 32236501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for morphea.
    Albuquerque JV; Andriolo BN; Vasconcellos MR; Civile VT; Lyddiatt A; Trevisani VF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005027. PubMed ID: 31309547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
    Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H
    J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.
    Condie D; Grabell D; Jacobe H
    Arthritis Rheumatol; 2014 Dec; 66(12):3496-504. PubMed ID: 25156342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea.
    García-Romero MT; Tollefson M; Pope E; Brandling-Bennett HA; Paller AS; Keimig E; Arkin L; Wanat KA; Humphrey SR; Werth VP; Oza V; Jacobe H; Fett N; Cordoro KM; Medina-Vera I; Chiu YE
    JAMA Dermatol; 2023 Mar; 159(3):299-307. PubMed ID: 36753150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
    Johnson W; Jacobe H
    J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
    Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
    Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized scleroderma: a clinical study at a single center in Korea.
    Noh JW; Kim J; Kim JW
    Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
    Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
    JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory arthritis in pediatric patients with morphea.
    Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
    J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with plaque type morphea mimicking systemic lupus erythematosus.
    Wardhana ; Datau EA
    Acta Med Indones; 2015 Apr; 47(2):146-52. PubMed ID: 26260557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.
    Mansour M; Liy Wong C; Zulian F; Li S; Morishita K; Yeh EA; Stewart K; Laxer RM; Pope E
    Pediatr Dermatol; 2018 Nov; 35(6):761-768. PubMed ID: 30187959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.
    Kumar AB; Blixt EK; Drage LA; El-Azhary RA; Wetter DA
    J Am Acad Dermatol; 2019 Jun; 80(6):1658-1663. PubMed ID: 30703458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.
    Vasquez R; Jabbar A; Khan F; Buethe D; Ahn C; Jacobe H
    J Am Acad Dermatol; 2014 Mar; 70(3):481-8. PubMed ID: 24365168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.